Jae-Kyo Kim
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Jae-Kyo Kim currently works at Hanmi Science Co., Ltd., as Vice Chairman & Chief Executive Officer from 2025.
Mr. Kim also formerly worked at Yuhan Corp., as Director & Head-Global Strategy.
Mr. Kim received his undergraduate degree from Kyungpook National University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Immuneoncia Therapeutics, Inc.
Immuneoncia Therapeutics, Inc. BiotechnologyHealth Technology Provides drug development and antibody engineering services for oncology patients 0,29 % | 30/04/2025 | 269 370 ( 0,29 % ) | 590 464 $ | 31/08/2026 |
HANMI SCIENCE CO., LTD 0,02 % | 27/08/2026 | 13 698 ( 0,02 % ) | 448 393 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HANMI SCIENCE CO., LTD. | Directeur Général | 26/03/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| YUHAN CORPORATION | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Yuhan Corp.
Yuhan Corp. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and marketing of pharmaceutical products | Health Technology |
Kyungpook National University
Kyungpook National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hanmi Science Co., Ltd.
Hanmi Science Co., Ltd. Medical DistributorsDistribution Services Operates as a holding company whose subsidiaries engages in pharmaceutical wholesale & manufacturing and medical device production activities | Distribution Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national